NPM1 and acute myeloid leukemia: In this context, AML subtypes that display a transcriptional similarity and co‐cluster with KMT2A‐r, NPM1‐mutant, and NUP98‐r AMLs, including those harboring UBTF‐TD and DEK::NUP214 may also show increased sensitivity towards Menin inhibition.140